Nobuaki Fujio

498 total citations
20 papers, 417 citations indexed

About

Nobuaki Fujio is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Nobuaki Fujio has authored 20 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Molecular Biology. Recurrent topics in Nobuaki Fujio's work include Heart Failure Treatment and Management (8 papers), Hormonal Regulation and Hypertension (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Nobuaki Fujio is often cited by papers focused on Heart Failure Treatment and Management (8 papers), Hormonal Regulation and Hypertension (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Nobuaki Fujio collaborates with scholars based in Japan. Nobuaki Fujio's co-authors include Masao Ōhashi, Hiroshi Ibayashi, Hajime Nawata, Hisayuki Matsuo, Kenji Kangawa, Kenichi Kato, H Nawata, H. Matsuo, Iwata Ozaki and Kiyoko Kato and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and Cellular and Molecular Life Sciences.

In The Last Decade

Nobuaki Fujio

19 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuaki Fujio Japan 11 166 104 100 67 50 20 417
Enrica Chebat Italy 10 83 0.5× 59 0.6× 98 1.0× 89 1.3× 48 1.0× 22 358
T. Berl United States 7 100 0.6× 280 2.7× 44 0.4× 118 1.8× 35 0.7× 9 479
R. D. Russ United States 11 115 0.7× 91 0.9× 52 0.5× 48 0.7× 30 0.6× 24 382
Franco Franchi Italy 16 330 2.0× 68 0.7× 46 0.5× 95 1.4× 9 0.2× 31 539
Anna P. Shapiro United States 11 68 0.4× 51 0.5× 70 0.7× 193 2.9× 23 0.5× 17 422
K Nakao Japan 11 87 0.5× 40 0.4× 162 1.6× 68 1.0× 8 0.2× 32 468
G. A. Charbon Netherlands 14 30 0.2× 52 0.5× 48 0.5× 92 1.4× 8 0.2× 42 450
Annika Adlerberth Sweden 10 100 0.6× 13 0.1× 202 2.0× 69 1.0× 11 0.2× 17 435
K Buchholz Germany 8 308 1.9× 30 0.3× 128 1.3× 52 0.8× 46 0.9× 9 484
Stephen C. Berens United States 10 124 0.7× 58 0.6× 144 1.4× 123 1.8× 22 0.4× 12 573

Countries citing papers authored by Nobuaki Fujio

Since Specialization
Citations

This map shows the geographic impact of Nobuaki Fujio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuaki Fujio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuaki Fujio more than expected).

Fields of papers citing papers by Nobuaki Fujio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuaki Fujio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuaki Fujio. The network helps show where Nobuaki Fujio may publish in the future.

Co-authorship network of co-authors of Nobuaki Fujio

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuaki Fujio. A scholar is included among the top collaborators of Nobuaki Fujio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuaki Fujio. Nobuaki Fujio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Kyosuke, Iwata Ozaki, Nobuaki Fujio, et al.. (1992). Overlap and discrepancy between tests for anti-C1OO, anti-GOR and anti-CP9 in patients with chronic liver disease and inhabitants in Saga, Japan. Gastroenterologia Japonica. 27(4). 502–507. 2 indexed citations
2.
Ozaki, Iwata, et al.. (1991). Albumin mRNA expression in human liver diseases and its correlation to serum albumin concentration. Gastroenterologia Japonica. 26(4). 472–476. 16 indexed citations
3.
Nawata, Hajime, Masao Ōhashi, Masafumi Haji, et al.. (1991). Atrial and brain natriuretic peptide in adrenal steroidogenesis. The Journal of Steroid Biochemistry and Molecular Biology. 40(1-3). 367–379. 32 indexed citations
4.
Yamamoto, Kyosuke, et al.. (1991). Prevalence of chronic liver diseases and anti-HCV antibodies in different districts of Saga, Japan. Gastroenterologia Japonica. 26(2). 157–161. 24 indexed citations
5.
Ozaki, Iwata, et al.. (1990). Increased laminin B1 mRNA levels in carbon tetrachloride-induced liver fibrosis in rats. Gastroenterologia Japonica. 25(3). 401–401. 2 indexed citations
6.
Ōhashi, Masao, Shoichi Natori, Nobuaki Fujio, Haruo Iguchi, & H Nawata. (1990). Secretory Protein 7B2. Hormone and Metabolic Research. 22(2). 114–116. 10 indexed citations
7.
Fujio, Nobuaki, Masao Ōhashi, Hajime Nawata, et al.. (1989). Cardiovascular, renal and endocrine effects of ??-human atrial natriuretic peptide in patients with Cushing??s syndrome and primary aldosteronism. Journal of Hypertension. 7(8). 653–659. 9 indexed citations
8.
Fujio, Nobuaki, H Nawata, Kenichi Kato, et al.. (1988). Human Atrial Natriuretic Polypeptide in Plasma of Patients with Anorexia Nervosa. Hormone and Metabolic Research. 20(11). 705–708. 5 indexed citations
9.
Ōhashi, Masao, Nobuaki Fujio, Hajime Nawata, Hisayuki Matsuo, & Kenichi Kato. (1988). α-Human atrial natriuretic polypeptide binding sites in human adrenal membrane fractions. Regulatory Peptides. 21(3-4). 271–278. 10 indexed citations
10.
Ōhashi, Masao, Nobuaki Fujio, Hajime Nawata, et al.. (1987). Pharmacokinetics of synthetic α-human atrial natriuretic polypeptide in normal men; effect of aging. Regulatory Peptides. 19(5-6). 265–272. 18 indexed citations
11.
Fujio, Nobuaki, Masao Ōhashi, Hajime Nawata, et al.. (1987). Unique distributions of natriuretic hormones in dog brain. Regulatory Peptides. 18(3-4). 131–137. 8 indexed citations
12.
Ōhashi, Masao, Nobuaki Fujio, Hajime Nawata, et al.. (1987). High Plasma Concentrations of Human Atrial Natriuretic Polypeptide in Aged Men*. The Journal of Clinical Endocrinology & Metabolism. 64(1). 81–85. 143 indexed citations
13.
Ōhashi, Masao, et al.. (1987). α-neoendorphin-like immunoreactivity in medullary carcinoma of the thyroid. Cancer. 59(2). 277–280. 4 indexed citations
14.
Ōhashi, Masao, Nobuaki Fujio, Hajime Nawata, et al.. (1987). Effects of .ALPHA.-human Atrial Natriuretic Polypeptide on Anterior Pituitary Function in Men.. Endocrinologia Japonica. 34(5). 659–663. 7 indexed citations
15.
Ōhashi, Masao, Nobuaki Fujio, Keisuke Kato, et al.. (1986). Effect of human α-atrial natriuretic polypeptide on adrenocortical function in man. Journal of Endocrinology. 110(2). 287–292. 28 indexed citations
16.
Ōhashi, Masao, Nobuaki Fujio, Kenichi Kato, Hajime Nawata, & Hiroshi Ibayashi. (1986). Aging Is without Effect on the Pituitary-Adrenal Axis in Men. Gerontology. 32(6). 335–339. 32 indexed citations
17.
Ōhashi, Masao, Nobuaki Fujio, & Hiroshi Ibayashi. (1986). Release of calcitonin gene-related peptide from a human medullary carcinoma of the thyroid in vitro. Cellular and Molecular Life Sciences. 42(7). 829–830. 5 indexed citations
18.
Fujio, Nobuaki, Masao Ōhashi, H Nawata, et al.. (1986). α‐HUMAN ATRIAL NATRIURETIC POLYPEPTIDE REDUCES THE PLASMA ARGININE VASOPRESSIN CONCENTRATION IN HUMAN SUBJECTS. Clinical Endocrinology. 25(2). 181–187. 42 indexed citations
19.
Fujio, Nobuaki, Masaki Ohashi, H Nawata, et al.. (1986). [A case of multiple endocrine neoplasia (MEN) type IIb].. PubMed. 75(12). 1781–6. 4 indexed citations
20.
Ōhashi, Masao, Nobuaki Fujio, Hajime Nawata, et al.. (1986). α-Human Atrial Natriuretic Polypeptide-Induced Rise of Plasma and Urinary Cyclic 3″5″-Guanosine Monophosphate Concentration in Human Subjects. Clinical and Experimental Hypertension Part A Theory and Practice. 8(1). 67–73. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enrica Chebat Breakdown of academic impact, for papers by T. Berl Breakdown of academic impact, for papers by R. D. Russ Breakdown of academic impact, for papers by Franco Franchi Breakdown of academic impact, for papers by Anna P. Shapiro Breakdown of academic impact, for papers by K Nakao Breakdown of academic impact, for papers by G. A. Charbon Breakdown of academic impact, for papers by Annika Adlerberth Breakdown of academic impact, for papers by K Buchholz Breakdown of academic impact, for papers by Stephen C. Berens
Rankless by CCL
2026